Neuroscientific Biopharmaceuticals Ltd Total Assets

Latest as of December 2025: AU$16.66 Million AUD ≈ $11.79 Million USD

Neuroscientific Biopharmaceuticals Ltd total assets. Based on the latest financial reports, Neuroscientific Biopharmaceuticals Ltd (NSB) holds total assets worth AU$16.66 Million AUD (≈ $11.79 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see NSB market cap overview for the company's overall valuation and market capitalisation.

Total Assets of Neuroscientific Biopharmaceuticals Ltd (2016–2025)

Total assets of Neuroscientific Biopharmaceuticals Ltd from 2016 to 2025. This chart illustrates how Neuroscientific Biopharmaceuticals Ltd's total assets have evolved over time, based on quarterly financial data. See latest Neuroscientific Biopharmaceuticals Ltd stock price today for real-time trading data and today's change.

Neuroscientific Biopharmaceuticals Ltd - Asset Composition Analysis

Neuroscientific Biopharmaceuticals Ltd Total Assets Breakdown (June 2025)

Neuroscientific Biopharmaceuticals Ltd total assets breakdown as of June 2025. Neuroscientific Biopharmaceuticals Ltd's total assets of AU$16.66 Million consist of 43.6% current assets and 56.4% non-current assets.

Asset Category	Amount (AUD)	% of Total Assets
Cash & Equivalents	AU$7.27 Million	42.8%
Accounts Receivable	AU$98.36K	0.6%
Inventory	AU$0.00	0.0%
Property, Plant & Equipment	AU$870.00	0.0%
Intangible Assets	AU$9.57 Million	56.4%
Goodwill	AU$0.00	0.0%

Asset Composition Trend (2016–2025)

This chart illustrates how Neuroscientific Biopharmaceuticals Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Neuroscientific Biopharmaceuticals Ltd (NSB) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Neuroscientific Biopharmaceuticals Ltd's current assets represent 43.6% of total assets in 2025, a decrease from 75.7% in 2016.
Cash Position: Cash and equivalents constituted 42.8% of total assets in 2025, up from 1.9% in 2016.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 56.0% of total assets, an increase from 24.0% in 2016.
Asset Diversification: The largest asset category is intangible assets at 56.4% of total assets.

Neuroscientific Biopharmaceuticals Ltd Competitors by Total Assets

Key competitors of Neuroscientific Biopharmaceuticals Ltd based on total assets are shown below.

Company	Country	Total Assets
Xizang Haisco Pharmaceutical Group Co Ltd SHE:002653	China	CN¥7.88 Billion
Halozyme Therapeutics Inc NASDAQ:HALO	USA	$2.22 Billion
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	China	CN¥37.46 Billion
Definium Therapeutics, Inc. NASDAQ:DFTX	USA	$1.11 Billion
Beijing Wantai Biological Pharmacy Enterprise Co Ltd SHG:603392	China	CN¥13.71 Billion
BB Biotech AG SW:BION	Switzerland	CHF3.09 Billion
Zealand Pharma A/S CO:ZEAL	Denmark	Dkr16.46 Billion
Xiamen Amoytop Biotech Co Ltd SHG:688278	China	CN¥3.21 Billion

Neuroscientific Biopharmaceuticals Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	31.62	179.30	25.02
Quick Ratio	31.62	179.30	25.02
Cash Ratio	5.33	172.79	24.04
Working Capital	AU$6.37 Million	AU$4.64 Million	AU$4.98 Million

Neuroscientific Biopharmaceuticals Ltd - Advanced Valuation Insights

This section examines the relationship between Neuroscientific Biopharmaceuticals Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.02
Latest Market Cap to Assets Ratio	0.75
Asset Growth Rate (YoY)	212.1%
Total Assets	AU$16.96 Million
Market Capitalization	$12.71 Million USD

Valuation Analysis

Below Book Valuation: The market values Neuroscientific Biopharmaceuticals Ltd's assets below their book value (0.75x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Neuroscientific Biopharmaceuticals Ltd's assets grew by 212.1% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Neuroscientific Biopharmaceuticals Ltd (2016–2025)

The table below shows the annual total assets of Neuroscientific Biopharmaceuticals Ltd from 2016 to 2025.

Year	Total Assets	Change
2025-06-30	AU$16.96 Million ≈ $12.00 Million	+212.05%
2024-06-30	AU$5.44 Million ≈ $3.85 Million	+2.74%
2023-06-30	AU$5.29 Million ≈ $3.74 Million	-31.62%
2022-06-30	AU$7.74 Million ≈ $5.47 Million	-47.82%
2021-06-30	AU$14.83 Million ≈ $10.49 Million	+296.70%
2020-06-30	AU$3.74 Million ≈ $2.64 Million	-27.05%
2019-06-30	AU$5.12 Million ≈ $3.63 Million	+533.37%
2018-06-30	AU$808.90K ≈ $572.35K	+39.72%
2017-06-30	AU$578.94K ≈ $409.64K	+134.79%
2016-06-30	AU$246.58K ≈ $174.47K	--

About Neuroscientific Biopharmaceuticals Ltd

AU:NSB Australia Biotechnology

Market Cap

$12.71 Million

AU$17.96 Million AUD

Market Cap Rank

#26298 Global

#1177 in Australia

Share Price

AU$0.05

Change (1 day)

+3.85%

52-Week Range

AU$0.05 - AU$0.17

All Time High

AU$0.52